Dáil Éireann Debate, Wednesday - 3 December 2025
254. Deputy Naoise Ó Muirí asked the Minister for Health the progress of licensing the drug luthera, which is required for the treatment of grade 4 neuroendocrine cancer; the expected timeline for approval; and if she will make a statement on the matter. [68274/25]
Amharc ar fhreagraUnder the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
